These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11285998)

  • 1. An update on glucocorticoid-induced osteoporosis.
    Lane NE
    Rheum Dis Clin North Am; 2001 Feb; 27(1):235-53. PubMed ID: 11285998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis.
    Boling EP
    Clin Ther; 2004 Jan; 26(1):1-14. PubMed ID: 14996513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs.
    Adler RA; Hochberg MC
    Arch Intern Med; 2003 Nov; 163(21):2619-24. PubMed ID: 14638562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on glucocorticoid-induced osteoporosis.
    Woolf AD
    Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-induced osteoporosis: pathogenesis, diagnosis, and management.
    McIlwain HH
    Prev Med; 2003 Feb; 36(2):243-9. PubMed ID: 12591000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial.
    Tamechika SY; Sasaki K; Hayami Y; Ohmura SI; Maeda S; Iwagaitsu S; Naniwa T
    Arch Osteoporos; 2018 Jun; 13(1):67. PubMed ID: 29904824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glucocorticoid-induced osteoporosis].
    Papierska L; Rabijewski M
    Pol Arch Med Wewn; 2007 Aug; 117(8):363-9. PubMed ID: 18018384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-induced osteoporosis and its treatment.
    Pennisi P; Trombetti A; Rizzoli R
    Clin Orthop Relat Res; 2006 Feb; 443():39-47. PubMed ID: 16462424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucocorticoid induced osteoporosis].
    Anić B; Mayer M
    Reumatizam; 2014; 61(2):105-12. PubMed ID: 25427404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.
    Popp AW; Isenegger J; Buergi EM; Buergi U; Lippuner K
    Eur Spine J; 2006 Jul; 15(7):1035-49. PubMed ID: 16474946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucocorticoid-induced osteoporosis].
    Tóth M; Tulassay Z
    Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced osteoporosis.
    Kumar R
    Curr Opin Nephrol Hypertens; 2001 Sep; 10(5):589-95. PubMed ID: 11496051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced osteoporosis.
    de Gregório LH; Lacativa PG; Melazzi AC; Russo LA
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):793-801. PubMed ID: 17117304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
    N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced osteoporosis: an update.
    Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
    Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-induced osteoporosis.
    Berris KK; Repp AL; Kleerekoper M
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-induced osteoporosis: is the bone density decrease the only explanation?
    Lespessailles E; Poupon S; Adriambelosoa N; Pothuaud L; Siroux V; Bouillon S; Benhamou CL
    Joint Bone Spine; 2000; 67(2):119-26. PubMed ID: 10769104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.